Zirk Matthias, Buller Johannes, Goeddertz Peter, Rothamel Daniel, Dreiseidler Timo, Zöller Joachim E, Kreppel Matthias
Department for Oral and Cranio-Maxillo and Facial Plastic Surgery (Head: Prof. Dr. Dr. Joachim E. Zöller), University of Cologne, Germany.
Department for Oral and Cranio-Maxillo and Facial Plastic Surgery (Head: Prof. Dr. Dr. Joachim E. Zöller), University of Cologne, Germany.
J Craniomaxillofac Surg. 2016 Aug;44(8):1081-8. doi: 10.1016/j.jcms.2016.05.019. Epub 2016 Jun 6.
Odontogenic infections may lead to severe head and neck infections with potentially great health risk. Age, location of purulent affected sites and beta-lactam allergy are some mentionable factors regarding patients' in-hospital stay and course of disease. Are there new challenges regarding bacteria' antibiotic resistance for empiric treatment and what influences do they have on patients' clinical course?
We analyzed in a 4-year retrospective study the medical records of 294 in-hospital patients with severe odontogenic infections. On a routine base bacteria were identified and susceptibility testing was performed. Length of stay in-hospital was evaluated regarding patients' age, beta-lactam allergy profile, affected sites and bacteria susceptibility to empiric antibiotics.
Length of stay in-hospital was detected to be associated with affected space and penicillin allergy as well (p < 0.05). Isolates presented large amounts of aerobic gram-positive bacteria (64.2%), followed by facultative anaerobic bacteria (gram+/15.8%, gram-/12.7%). Tested ampicillin in combination with sulbactam (or without) and cephalosporins displayed high susceptibility rates, revealing distinguished results regarding clindamycin (p < 0.05). Co-trimoxazol and moxifloxacin showed high overall susceptibility rates (MOX: 94.7%, COTRIM: 92.6%).
This study demonstrates ampicillin/sulbactam in addition to surgical intervention is a good standard in treatment of severe odontogenic neck infections. Cephalosporins seem to be a considerable option as well. If beta-lactam allergy is diagnosed co-trimoxazol and moxifloxacin represent relevant alternatives.
Age, allergic profile and bacteria' resistance patterns for empiric antibiotics have an influence on patients in-hospital stay. Ampicillin/sulbactam proves itself to be good for empiric antibiosis in severe odontogenic infections. Furthermore cephalosporins could be considered as another option in treatment. However moxifloxacin and co-trimoxazol deserves further investigation as empiric antibiosis in odontogenic infections if beta-lactam allergy is diagnosed.
牙源性感染可能导致严重的头颈部感染,存在极大的健康风险。年龄、化脓性感染部位以及β-内酰胺类过敏是影响患者住院时间和病程的一些值得提及的因素。对于经验性治疗而言,细菌的抗生素耐药性是否带来了新的挑战?这些耐药性对患者的临床病程又有何影响?
我们进行了一项为期4年的回顾性研究,分析了294例因严重牙源性感染住院患者的病历。常规鉴定细菌并进行药敏试验。根据患者年龄、β-内酰胺类过敏情况、感染部位以及细菌对经验性抗生素的敏感性评估住院时间。
发现住院时间与感染部位以及青霉素过敏也有关联(p < 0.05)。分离出大量需氧革兰氏阳性菌(64.2%),其次是兼性厌氧菌(革兰氏阳性菌/15.8%,革兰氏阴性菌/12.7%)。测试的氨苄西林联合舒巴坦(或不联合)以及头孢菌素显示出较高的敏感率,克林霉素的结果则有显著差异(p < 0.05)。复方新诺明和莫西沙星总体敏感率较高(莫西沙星:94.7%,复方新诺明:92.6%)。
本研究表明,除手术干预外,氨苄西林/舒巴坦是治疗严重牙源性颈部感染较好的标准用药。头孢菌素似乎也是一个不错的选择。如果诊断为β-内酰胺类过敏,复方新诺明和莫西沙星是相关的替代药物。
年龄、过敏情况以及经验性抗生素的细菌耐药模式会影响患者的住院时间。氨苄西林/舒巴坦在严重牙源性感染的经验性抗菌治疗中表现良好。此外,头孢菌素可作为另一种治疗选择。然而,如果诊断为β-内酰胺类过敏,莫西沙星和复方新诺明作为牙源性感染经验性抗菌药物值得进一步研究。